Irja Davidkin
Finnish Institute for Health and Welfare · 106 works · 3,669 citations · h-index 33
Top works
- Explosive School-based Measles Outbreak: Intense Exposure May Have Resulted in High Risk, Even among Revaccinees
- Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up
- No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study
- Persistence of Measles, Mumps, and Rubella Antibodies in an MMR‐Vaccinated Cohort: A 20‐Year Follow‐up
- Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue
- High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland
- The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region
- Waning Antibody Levels and Avidity: Implications for MMR Vaccine-Induced Protection
- Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts
- Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age
- Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up
- Etiology of Measles‐ and Rubella‐like Illnesses in Measles, Mumps, and Rubella–Vaccinated Children
- The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella
- The seroepidemiology of measles in Western Europe
- Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme
- Etiology of Mumps‐Like Illnesses in Children and Adolescents Vaccinated for Measles, Mumps, and Rubella
- Allergic Reactions to Measles-Mumps-Rubella Vaccination
- No measles in Finland
- Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland
- Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection